Brand Intelligence Graph
Company Overview
About Muna Therapeutics
Muna Therapeutics focuses on microglial biology — the specialized immune cells of the brain — as the key to developing disease-modifying Alzheimer's therapies beyond amyloid targeting. The company uses induced pluripotent stem cell (iPSC)-derived microglia as disease models to identify and validate novel drug targets implicated by Alzheimer's genetics (TREM2, PLCG2, BIN1, APOE). This platform enables the company to study microglial dysfunction at scale and run drug screens against human-relevant cellular models.
Business Model & Competitive Advantage
Founded in Copenhagen in 2020 with co-founders from the UK Dementia Research Institute, Muna raised $75M in 2024 and is advancing multiple small molecule and antibody programs targeting TREM2 agonism and related microglial activation pathways. The company's approach differs from antibody-based TREM2 programs (Alector, Vigil Neuroscience) by pursuing oral small molecules that can penetrate the blood-brain barrier.
Competitive Landscape 2025–2026
With Alzheimer's affecting 55 million people worldwide and limited options beyond recently approved anti-amyloid antibodies, microglial biology represents one of the most genetics-validated unexplored therapeutic avenues. Muna's iPSC platform advantage enables rapid target validation cycles that outpace traditional neuroscience drug discovery timelines.
Key Differentiators
Emerging Innovator
Muna Therapeutics is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
NEOK Bio
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Compare Muna Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Muna Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Muna Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Muna Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →